← Back
▼ SELL

$ Value

$14K

Shares

11,000

Price

$1

Filed

Jun 2

Insider

Name

Soffer Rock

Title

CIK

0001845308

Roles

Director

Transaction Details

Transaction Date

2025-05-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

209,034

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.305, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.255, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. | Includes RSUs subject to future vesting. | Share amounts include 41,010 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

Filing Info

Accession No.

0001214659-25-008715

Form Type

4

Issuer CIK

0001721484

Soffer Rock's History

Date Ticker Type Value
2025-07-15 LGVN A $0
2025-05-30 LGVN $14K
2025-05-29 LGVN $13K
2025-05-22 LGVN $3K

Other Insiders at LGVN (90d)

Insider Bought Sold Last
Willard Stephen H
Chief Executive Officer
2026-04-01
Lehr Paul T
General Counsel, Secretary
2026-04-01
Agafonova Nataliya
Chief Medical Officer
2026-04-01
Locklear Lisa
Chief Financial Officer
2026-04-01
Blass Devin
CTO & SVP of CMC
2026-04-01